{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Corona",
      "state": "CA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80397",
      "recalling_firm": "Aidarex Pharmaceuticals LLC",
      "address_1": "595 N Smith Ave",
      "address_2": "N/A",
      "postal_code": "92880-6920",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed Nationwide in the USA",
      "recall_number": "D-0991-2018",
      "product_description": "Enalapril Maleate, USP 5MG, 90-count bottle, RX only. Packaged By: Aidarex Pharmaceuticals. Mfg: Wockhardt Ltd. India.  NDC: 33261-0693-90",
      "product_quantity": "61, 90-count bottles",
      "reason_for_recall": "Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.",
      "recall_initiation_date": "20180627",
      "center_classification_date": "20180725",
      "termination_date": "20191204",
      "report_date": "20180801",
      "code_info": "Lots: 51904-1, EXP: 01/31/2018; 51904-4, 52885-1, EXP: 03/31/2018; 52885-3, EXP: 04/30/2018; 52885-4,EXP: 05/28/2018; 53840-2,EXP: 5/28/2018; 53840-3, EXP:6/30/2018; 53840-4,  EXP:8/31/2018; 56665-1, EXP: 01/31/2019;  58596-1, EXP: 05/28/2019."
    }
  ]
}